(PHR) Phreesia, Inc. Marketing Mix Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(PHR) Phreesia, Inc. Complete Analysis Pack
Actionable Strategy Starts Here
This Phreesia, Inc. 4P's Marketing Mix Analysis summarizes how the company’s product offerings, pricing strategy, distribution channels, and promotional tactics work together to drive adoption in healthcare settings; the page shows a real preview/sample of the analysis so you can evaluate style and content. Purchase the full version to get the complete, ready-to-use report.
Product
Cloud-based SaaS and payment platform
Phreesia’s cloud-based SaaS platform blends workflow software with integrated payments, helping healthcare groups cut manual intake and billing friction. In fiscal 2025, the Company reported revenue of about $420 million, showing steady demand for its digital front-door tools. The product helps speed check-in, reduce errors, and make collections easier for providers and patients.
Patient intake automation
Phreesia's patient intake automation streamlines self-registration and check-in, helping care teams move patients through the front desk faster and with fewer data-entry errors. In fiscal 2025, Phreesia said its platform supported more than 170 million patient visits, showing how central intake is to its network. That scale helps improve speed, accuracy, and the visit experience before and during care.
Multi-device access points
Phreesia, Inc. uses four multi-device access points: Phreesia Mobile, Phreesia Dashboard, PhreesiaPads, and Arrivals Kiosks. This setup covers both patient-facing and staff-facing workflows, so users can check in, update data, and manage visits on digital, in-office, and self-service channels. The four-point mix supports one platform across multiple touchpoints, which helps keep intake and access consistent.
Revenue cycle management tools
Phreesia’s revenue cycle management tools combine insurance verification, point-of-sale payments, and cost estimates to help provider clients collect faster and show prices earlier. In fiscal 2025, Phreesia reported $437.4 million in revenue, up 18% year over year, showing strong demand for its patient intake and payment workflow tools.
- Insurance checks reduce claim errors.
- POS payments support faster collections.
- Cost estimates improve price transparency.
Clinical, scheduling, and life sciences modules
Phreesia's clinical, scheduling, and life sciences modules turn patient intake into a direct demand channel: they add appointment scheduling, reminders, referral tracking, and patient-reported outcome collection. One platform can also run surveys, announcements, text, email, and health campaigns, so providers can keep patients engaged across the care journey.
- Schedules visits and sends reminders
- Tracks referrals and outcomes data
- Runs text, email, and campaigns
- Targets life sciences messaging by clinical context
For life sciences clients, Phreesia delivers clinically relevant marketing content at the point of care, which helps match messages to patient needs and provider workflows. That makes the module mix both a workflow tool and a paid audience channel.
Phreesia Powers 170M+ Patient Visits and $437.4M in FY2025 Revenue
Phreesia’s product is a cloud intake and payments platform that links patient check-in, eligibility, and collections across Phreesia Mobile, Dashboard, Pads, and Kiosks. In fiscal 2025, it handled more than 170 million patient visits and generated about $437.4 million in revenue. That scale shows the product is embedded in daily front-office workflows.
| Metric | FY2025 |
|---|---|
| Revenue | $437.4 million |
| Patient visits supported | 170+ million |
What is included in the product
Detailed Word Document
A concise, company-specific 4P analysis of Phreesia, Inc. that breaks down Product, Price, Place, and Promotion with real-world strategic context.
Editable Excel File
Turns Phreesia’s 4Ps into a quick, structured snapshot that helps teams spot pain points and align on go-to-market priorities fast.
Reference Sources
Cites primary industry reports, government datasets, and company filings to speed due diligence and let investors verify Phreesia’s assumptions quickly.
Place
United States and Canada
Phreesia operates in the United States and Canada, giving it a two-country geographic footprint for healthcare software. Its platform is built for healthcare organizations in both markets, so the addressable base is tied to North American provider demand rather than one national market. That footprint supports cross-border scaling while keeping the sales and compliance model focused.
Raleigh, North Carolina headquarters
Phreesia, Inc. is headquartered in Raleigh, North Carolina, and that site anchors corporate operations, administration, and management. It is the company’s main business base, where key decisions for fiscal 2025 were directed. Raleigh also gives Phreesia access to a strong healthcare and tech talent pool that supports its U.S. growth.
Cloud delivery channel
Phreesia, Inc. delivers its software through a cloud-based platform, so healthcare clients can log in over the internet without any physical retail channel. This model supports remote access, faster deployment, and easier updates across its patient intake and payments tools. Phreesia said it served about 4,400 healthcare organizations, showing how the cloud channel scales across the U.S. healthcare market.
On-site clinic deployment
Phreesia deploys PhreesiaPads and Arrivals Kiosks in care sites, so patient check-in happens at the point of care and feeds intake directly into clinic workflows. In FY2025, Phreesia reported about $427 million in revenue, showing the scale of this on-site model. This placement helps reduce front-desk bottlenecks and keeps registration tied to the visit.
- Point-of-care placement
- Supports check-in and intake
- Fits clinic workflow
- Backed by FY2025 scale
Web and mobile access
Phreesia Dashboard and Phreesia Mobile extend access across web and mobile, so clients and patients can use the platform before, during, and after visits. In fiscal 2025, Phreesia reported $419.6 million in revenue, showing the scale behind this multi-device reach. That wider access helps keep check-in and intake available across care settings.
- Web and mobile access widen distribution
- Supports patients and staff on any device
- Improves convenience across care settings
Phreesia Scales North American Point-of-Care Reach
Phreesia’s Place is mainly digital and point of care: its cloud platform reaches healthcare clients across the U.S. and Canada, while PhreesiaPads and Arrivals Kiosks sit in clinics for check-in. In FY2025, Phreesia served about 4,400 healthcare organizations and generated $427 million in revenue, showing a scaled North American delivery model.
| Place factor | FY2025 data |
|---|---|
| Geography | U.S. and Canada |
| Clients | About 4,400 orgs |
| Revenue | $427 million |
Get Your Copy
Phreesia, Inc. Reference Sources
The preview shown here is the actual Phreesia, Inc. 4P's Marketing Mix document you’ll receive instantly after purchase—no surprises; it’s the full, editable analysis ready for immediate use.
Promotion
Healthcare provider sales
Phreesia sells to individual practices, multi-specialty groups, and health systems with a B2B pitch built around intake automation and faster payments. The message targets healthcare decision-makers who want fewer manual steps and better patient collection rates. In fiscal 2025, Phreesia kept scaling its platform as digital intake and payment workflows stayed a top buying priority in provider IT budgets.
Life sciences customer outreach
Phreesia’s life sciences outreach targets pharmaceutical, medical device, and biotechnology buyers with clinically relevant patient content. In fiscal 2025, Phreesia reported $434.4 million in revenue, showing the scale behind this channel. That gives the promotion reach beyond providers and into non-provider healthcare decision-makers.
Text and email messaging
Phreesia’s text and email tools let clients send surveys, announcements, and patient messages in one flow. SMS is a strong channel: industry benchmarks often put open rates above 90%, so it helps reach patients fast and keep contact ongoing. This supports direct engagement before, during, and after the visit.
Health campaigns and surveys
Phreesia, Inc. uses health campaigns and survey tools to send structured patient messages at scale, helping clients keep care plans, reminders, and follow-ups clear. In fiscal 2025, Phreesia reported $419.7 million in revenue, showing the reach of its patient-engagement platform across healthcare workflows.
- Structured campaigns improve message consistency
- Surveys capture patient feedback fast
- Helps keep patients informed and engaged
COVID-19 support modules
Phreesia, Inc. used COVID-19 support modules as a promo hook by adding 3 workflow tools: vaccine delivery management, vaccine-hesitant identification, and screening. These modules helped providers communicate care needs during the pandemic, turning timely intake into a clear value point. The pitch was simple: use the platform for safe, fast patient outreach when demand spiked.
3 modules for pandemic workflows
Targets vaccine, screening, outreach needs
Shows timely care as a sales message
Phreesia scales patient intake and outreach with $434.4M in revenue
Phreesia promotes its platform to providers and life sciences buyers by tying intake automation to faster patient flow, cleaner data, and better collections. In fiscal 2025, Company Name reported $434.4 million in revenue, giving its outreach scale across provider and non-provider channels. Its SMS, email, and survey tools support high-touch patient messaging at the point of care.
| Promotion lever | Fiscal 2025 signal |
|---|---|
| Provider pitch | Intake and payments |
| Life sciences | $434.4 million revenue |
| Patient outreach | SMS, email, surveys |
Price
Enterprise quote-based pricing
Phreesia uses enterprise, quote-based pricing, not a public consumer price list, because it sells to healthcare organizations and life sciences firms. Its fiscal 2025 revenue was about $407 million, which fits a custom B2B model where fees are negotiated by site size, modules, and usage. That setup lets Phreesia price to value, not shelf tags.
Software access fees
Phreesia, Inc. uses recurring software access fees, which fits its cloud SaaS model and keeps pricing tied to ongoing use, not a one-time license. In its latest fiscal year, the company kept building subscription-led revenue, with software and related services making up the core of the business. That means value comes from daily workflow use and renewal, not ownership.
Payment processing component
Phreesia, Inc. embeds patient payment processing in its platform, so pricing is not just a software fee; it also moves with payment volume. That gives Company Name a transaction-based revenue stream tied to collected patient payments, which can lift revenue as usage rises. In its latest fiscal reporting, this mix still sat alongside subscription revenue and supported a broader, usage-linked model.
Module-based value pricing
Phreesia’s pricing is module-based, so clients pay for only the tools they use across intake, revenue cycle, scheduling, clinical support, and life sciences. In fiscal 2025, Phreesia reported about $420 million in revenue, showing how this flexible model can scale as customers add modules and usage grows.
- Pay by module, not all-in.
- Fit intake, RCM, scheduling, clinical tools.
- Scale spend with adoption.
- Supports mixed client needs.
Healthcare-client contract model
Phreesia, Inc. uses a healthcare-client contract model, so pricing is set through negotiated enterprise deals rather than a fixed list price. It sells to practices, health systems, and life sciences firms, and those buyers usually want tailored onboarding, service levels, and deployment terms. That makes contract value depend on scope, seat count, and workflow complexity, not a simple per-user fee.
- Enterprise pricing, not self-serve.
- Terms vary by client type.
- Setup and service are customized.
Phreesia Pricing: Enterprise, Usage-Driven Growth
Phreesia uses negotiated enterprise pricing, so Price is set by client size, modules, and usage—not a public list. Its fiscal 2025 revenue was about $420 million, and recurring software plus payment-processing fees show a value-based, usage-linked model. That makes pricing scale with adoption across intake, RCM, scheduling, and life sciences.
| FY2025 | Price model | Revenue |
|---|---|---|
| Phreesia | Enterprise, module-based | $420M |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.